Spot on.
This is the key quote: "The abstract, titled ‘CF33-hNIS, a novel oncolytic virus for the treatment of cholangiocarcinoma and biliary tract malignancies,’ concludes that CF33-hNIS monotherapy may be an effective and safe treatment option for GI malignancies, including cholangiocarcinoma, a rare disease with an unmet medical need."
That they are presenting with the above as the key message suggests that the results continue to stack up and they are becoming increasingly more confident of CF33 meeting the until now unmet need.
Whilst this is a rare condition in the US with "only" about 10,000 cases each year, it is way more common in Asia (by a factor of up to 6x per head of population) including a number of wealthy countries (Japan, Singapore, Taiwan, etc) with capacity to pay. Unmet need + capacity to pay = a massive financial opportunity in the near term for IMU.
If indeed the later and expanded trial results (when released) speak to the same outcomes that got them FDA fast track, then we could see this as a product in market as soon as next year. On which case I believe that there will be major players already warming up to do a deal.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-21
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $339.4K | 6.365M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 895592 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 672708 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 845592 | 0.053 |
21 | 2719942 | 0.052 |
37 | 3800174 | 0.051 |
70 | 5690066 | 0.050 |
16 | 2155346 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 672708 | 10 |
0.055 | 2964674 | 13 |
0.056 | 2227496 | 13 |
0.057 | 1068065 | 8 |
0.058 | 725800 | 5 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online